April 5, 2026 5:46 AM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Cannabis

Cannabis Latest 

Tilray Brands Proposes Reverse Split Of Up To 20-To-1 To Regain Nasdaq Compliance

April 17, 2025 9:16 AMApril 17, 2025 9:16 AM Jay Lutz 0 Comments Tilray

Tilray Brands (TSX: TLRY) is seeking shareholder approval to conduct a reverse stock split in an effort to regain compliance

Share
Tweet
Share
Reddit
Read more
Cannabis Full Analysis Latest Video Series 

Tilray Brands Q3 Earnings Analysis: Behind The CEO’s “Robust” Claims

April 12, 2025 3:28 PMApril 12, 2025 12:31 AM Jay Lutz 0 Comments Tilray

“Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning the beverage, cannabis, and wellness

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray Q3 FY2025 Results: Shares Slump On 656% Wider Net Loss

April 10, 2025 7:21 AMApril 9, 2025 7:29 PM ER Velasco 0 Comments Tilray

Tilray Brands (TSX: TLRY) has reported its financial results for Q3 of fiscal 2025, ending February 28. The company’s net

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Gold Flora Corp Files for Voluntary Receivership Amid Mounting Debt

March 31, 2025 8:00 AMMarch 31, 2025 8:00 AM JP Alegre 0 Comments Gold Flora Corporation

Gold Flora Corporation (CBOE: GRAM), a prominent California cannabis company with annual revenues exceeding $100 million, has filed for voluntary

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

SNDL Reports Record Annual Revenue in 2024, But Still Posts An Operating Loss

March 18, 2025 11:29 AMMarch 18, 2025 10:32 AM ER Velasco 0 Comments SNDL

SNDL (NASDAQ: SNDL) has reported its Q4 and full-year 2024 financial and operational results, reporting $257.7 million in quarterly net

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Simply Solventless To Acquire CanadaBis Capital For $0.116 A Share In All-Stock Deal

March 12, 2025 9:08 AMMarch 12, 2025 9:08 AM Jay Lutz 0 Comments CanadaBis Capital, Simply Solventless

Less than two weeks after closing its acquisition of Delta 9 Bio-Tech, Simply Solventless (TSXV: HASH) has entered into another

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Trulieve Cannabis Sees Another CFO Resign

March 7, 2025 8:48 AMMarch 7, 2025 8:48 AM Jay Lutz 0 Comments Trulieve Cannabis

Trulieve Cannabis (CSE: TRUL) has again seen a change in the role of chief financial officer. The company this morning

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Curaleaf Reports $216M Net Loss in 2024 Despite $1.34B Revenue

March 4, 2025 8:01 AMMarch 4, 2025 7:45 AM ER Velasco 0 Comments Curaleaf, Curaleaf Holdings

Curaleaf Holdings (TSX: CURA) reported a net loss of $216.2 million for 2024 which, while slightly improved from the $238.9 million loss

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Fetterman Launches Petition Drive for Federal Marijuana Legalization

February 26, 2025 10:04 AMFebruary 26, 2025 3:02 AM JP Alegre 0 Comments Cannabis Legalization News, John Fetterman

Pennsylvania Democratic Senator John Fetterman has initiated a petition campaign urging federal marijuana legalization, calling it a “vital chance” to

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Acting DEA Chief Says Cannabis Review Is Not Dead—Yet—as Successor Looms

February 12, 2025 12:47 PMFebruary 12, 2025 10:00 AM JP Alegre 1 Comment Cannabis Legalization News, Cannabis Legislation, cannabis scheduling, DEA, Derek Maltz, Drug Enforcement Administration, Terrance Cole

Trump nominee Cole’s anti-cannabis stance could alter course

Share
Tweet
Share
Reddit
Read more
  • ← Previous

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Annie Altman, OpenAI CEO's Sister, Tweets About Sexual Abuse Suffered From "Brother" Sam Altman
  • Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing
  • Commodities And The New World Order: What You Need To Know From Zoltan Pozsar's Bretton Woods III
  • X Changes Policy to Now Allow Adult Content
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.